tiprankstipranks
Trending News
More News >
Taiko Pharmaceutical Co., Ltd. (JP:4574)
:4574
Japanese Market

Taiko Pharmaceutical Co., Ltd. (4574) Income Statement

Compare
0 Followers

Taiko Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q4 2024), Taiko Pharmaceutical Co., Ltd.'s total revenue was ¥1.71B, an increase of 29.67% from the same quarter last year. In Q4, Taiko Pharmaceutical Co., Ltd.'s net income was ¥184.00M. See Taiko Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 22Dec 21Dec 20Mar 20
Total Revenue
¥ 6.29B¥ 5.04B¥ 10.72B¥ 17.68B¥ 14.94B
Gross Profit
¥ 3.67B¥ 1.08B¥ 2.75B¥ 12.42B¥ 10.58B
Operating Expenses
¥ 3.04B¥ 4.16B¥ 7.69B¥ 6.77B¥ 6.75B
Depreciation and Amortization
¥ 256.00M¥ -671.00M¥ -620.00M¥ 272.52M¥ 495.20M
EBITDA
¥ 882.00M¥ -3.75B¥ -5.57B¥ 5.92B¥ 4.07B
Operating Income
¥ 629.00M¥ -3.08B¥ -4.95B¥ 5.65B¥ 3.82B
Other Income/Expenses
¥ -64.00M¥ -1.79B¥ -3.94B¥ -276.72M¥ -320.25M
Pretax Income
¥ 565.00M¥ -4.87B¥ -8.89B¥ 5.37B¥ 3.50B
Net Income
¥ 898.00M¥ -4.89B¥ -9.59B¥ 3.85B¥ 2.45B
Per Share Metrics
Basic EPS
¥ 17.89¥ -112.24¥ -220.48¥ 89.18¥ 57.57
Diluted EPS
¥ 17.89¥ -112.24¥ -220.48¥ 88.82¥ 57.34
Weighted Average Shares Outstanding
50.18M 43.60M 43.51M 43.19M 42.62M
Weighted Average Shares Outstanding (Diluted)
50.18M 43.60M 43.51M 43.36M 42.79M
Currency in JPY

Taiko Pharmaceutical Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis